Skip to main content
HTCR
NASDAQ Technology

HeartCore Enterprises Reports Steep Q1 Revenue Decline, Gross Profit Collapse, and Going Concern Warning

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
9
Price
$2.85
Mkt Cap
$3.497M
52W Low
$2.72
52W High
$33.4
Market data snapshot near publication time

summarizeSummary

HeartCore Enterprises reported a sharp decline in Q1 revenues and gross profit, along with a critical going concern warning, highlighting severe financial challenges and a precarious cash position.


check_boxKey Events

  • Q1 2026 Financial Deterioration

    Revenues decreased by 40.5% to $1.25 million, and gross profit plummeted by 86.4% to $74,045 compared to Q1 2025, primarily due to intense competition in the U.S. software market.

  • Going Concern Warning Issued

    Management explicitly stated "substantial doubt about the Company's ability to continue as a going concern" due to a critically low cash balance of $0.774 million and continued operating cash burn.

  • Critically Low Cash Position

    Cash and cash equivalents fell to $0.774 million as of March 31, 2026, from $1.99 million at year-end 2025, with net cash used in operating activities of $1.15 million in Q1 2026.

  • Material Weakness in Internal Controls

    The company's disclosure controls and procedures were deemed ineffective as of March 31, 2026, reiterating a material weakness previously disclosed in its annual report.


auto_awesomeAnalysis

HeartCore Enterprises' Q1 2026 results reveal a severe 40.5% drop in revenues and an 86.4% collapse in gross profit, primarily due to intense competition in the U.S. software market. The company explicitly states "substantial doubt about its ability to continue as a going concern" due to a critically low cash balance of $0.774 million and continued operating cash burn. This financial distress is compounded by an accumulated deficit of $15.6 million and ongoing material weaknesses in internal controls. While the net loss improved year-over-year, the overall financial health remains precarious, indicating significant operational challenges and an urgent need for additional funding.

At the time of this filing, HTCR was trading at $2.85 on NASDAQ in the Technology sector, with a market capitalization of approximately $3.5M. The 52-week trading range was $2.72 to $33.40. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed HTCR - Latest Insights

HTCR
May 15, 2026, 8:36 AM EDT
Filing Type: 10-Q
Importance Score:
9
HTCR
May 15, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
9
HTCR
Apr 22, 2026, 8:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
HTCR
Apr 01, 2026, 8:05 AM EDT
Filing Type: 8-K
Importance Score:
9
HTCR
Apr 01, 2026, 8:05 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
HTCR
Mar 31, 2026, 4:45 PM EDT
Source: Wiseek News
Importance Score:
8
HTCR
Mar 31, 2026, 4:35 PM EDT
Filing Type: 10-K
Importance Score:
9
HTCR
Feb 24, 2026, 8:30 AM EST
Filing Type: 8-K
Importance Score:
9
HTCR
Feb 11, 2026, 8:30 AM EST
Filing Type: 8-K
Importance Score:
8